Fmr LLC Abb Vie Inc. Transaction History

Fmr LLC

$1.81 Trillion
Q3 2025

A detailed history of Fmr LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fmr LLC holds 21,035,087 shares of ABBV stock, worth $4.92 Billion. This represents 0.27% of its overall portfolio holdings.

Number of Shares

21,035,087

Previous 21,001,617 0.16%

Holding current value

$4.92 Billion

Previous $3.9 Billion 24.94%

% of portfolio

0.27%

Previous 0.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$184.85 - $231.54 $6.19 Million - $7.75 Million	33,470 Added 0.16%	21,035,087 $4.87 Billion
Q2 2025 Aug 14, 2025	SELL	$170.16 - $206.27 $448 Million - $544 Million	-2,634,965 Reduced 11.15%	21,001,617 $3.9 Billion
Q1 2025 May 12, 2025	BUY	$169.2 - $216.66 $937 Million - $1.2 Billion	5,539,207 Added 30.61%	23,636,582 $4.95 Billion
Q4 2024 Feb 13, 2025	BUY	$164.99 - $203.87 $737 Million - $911 Million	4,466,971 Added 32.77%	18,097,375 $3.22 Billion
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $83.8 Million - $102 Million	511,470 Added 3.9%	13,630,404 $2.69 Billion

Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $97.6 Million - $114 Million	630,537 Added 5.05%	13,118,934 $2.25 Billion
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $223 Million - $255 Million	1,397,770 Added 12.6%	12,488,397 $2.27 Billion
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $24.9 Million - $28 Million	-180,845 Reduced 1.6%	11,090,627 $1.72 Billion
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $49.7 Million - $57.5 Million	371,842 Added 3.41%	11,271,472 $1.68 Billion
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $263 Million - $327 Million	-1,985,856 Reduced 15.41%	10,899,630 $1.47 Billion
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $214 Million - $246 Million	-1,478,010 Reduced 10.29%	12,885,486 $2.05 Billion
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $90.7 Million - $109 Million	-655,720 Reduced 4.37%	14,363,496 $2.32 Billion
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $321 Million - $368 Million	-2,392,966 Reduced 13.74%	15,019,216 $2.02 Billion
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $164 Million - $209 Million	-1,194,012 Reduced 6.42%	17,412,182 $2.67 Billion
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $204 Million - $253 Million	1,542,954 Added 9.04%	18,606,194 $3.02 Billion
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $489 Million - $619 Million	-4,553,434 Reduced 21.06%	17,063,240 $2.31 Billion
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $1.47 Billion - $1.67 Billion	-13,840,304 Reduced 39.03%	21,616,674 $2.33 Billion
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $3.73 Billion - $4.16 Billion	35,456,978 New	35,456,978 $3.99 Billion

Others Institutions Holding ABBV

# of Institutions

4,489

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account